机译:全基因组途径的多能性表征
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada;
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada,Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5T 3H7, Canada;
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada;
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands,Netherlands Proteomics Centre, Padualaan 8, 3584CH Utrecht, The Netherlands;
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada,Institute of Medical Science, University of Toronto, Toronto, Ontario M5T 3H7, Canada;
Genome Biology Department, The John Curtin School of Medical Research, The Australian National University, Acton (Canberra), ACT 2601, Australia;
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia;
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada;
Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul 110-799, South Korea,Department of Biomedical Sciences and Biochemistry, Seoul National University College of Medicine, Seoul 110-799, South Korea;
Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia,QIMR Berghofer Medical Research Institute, Genomic Biology Lab, 300 Herston Road, Herston, Queensland 4006, Australia;
Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia;
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands,Netherlands Proteomics Centre, Padualaan 8, 3584CH Utrecht, The Netherlands,Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain;
Gene and Stem Cell Therapy Program and Bioinformatics Lab, Centenary Institute, Camperdown 2050, NSW, Australia & Sydney Medical School, 31 University of Sydney 2006, New South Wales, Australia;
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia;
Genome Biology Department, The John Curtin School of Medical Research, The Australian National University, Acton (Canberra), ACT 2601, Australia,Genome Discovery Unit, The John Curtin School of Medical Research, The Australian National University, Acton (Canberra) 2601, ACT, Australia;
Institute of Biomaterials and Biomedical Engineering (IBBME), University of Toronto, Toronto M5S-3G9, Canada,The Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto M5S 3E1, Canada;
Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul 110-799, South Korea,Life Science Institute, Macrogen Inc., Seoul 153-781, South Korea;
Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia;
Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia,The University of Queensland Diamantina Institute, Translational Research Institute, 37 Kent Street, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia;
Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul 110-799, South Korea,Department of Biomedical Sciences and Biochemistry, Seoul National University College of Medicine, Seoul 110-799, South Korea;
Department of Systems & Computational Biology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461, USA;
Institute of Biomaterials and Biomedical Engineering (IBBME), University of Toronto, Toronto M5S-3G9, Canada;
Gene and Stem Cell Therapy Program and Bioinformatics Lab, Centenary Institute, Camperdown 2050, NSW, Australia & Sydney Medical School, 31 University of Sydney 2006, New South Wales, Australia;
Gene and Stem Cell Therapy Program and Bioinformatics Lab, Centenary Institute, Camperdown 2050, NSW, Australia & Sydney Medical School, 31 University of Sydney 2006, New South Wales, Australia,Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown 2050, New South Wales, Australia;
Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia;
Institute of Biomaterials and Biomedical Engineering (IBBME), University of Toronto, Toronto M5S-3G9, Canada,The Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto M5S 3E1, Canada;
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia,College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK;
Genome Biology Department, The John Curtin School of Medical Research, The Australian National University, Acton (Canberra), ACT 2601, Australia,Victor Chang Cardiac Research Institute, Darlinghurst (Sydney), New South Wales 2010, Australia;
Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul 110-799, South Korea,Department of Biomedical Sciences and Biochemistry, Seoul National University College of Medicine, Seoul 110-799, South Korea,Life Science Institute, Macrogen Inc., Seoul 153-781, South Korea;
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands,Netherlands Proteomics Centre, Padualaan 8, 3584CH Utrecht, The Netherlands;
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada,Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada,Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario M5S 1E2, Canada;
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada,Institute of Medical Science, University of Toronto, Toronto, Ontario M5T 3H7, Canada,Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario M5S 1E2, Canada;
机译:全能性途径的全基因组表征(第516卷,第198页,2014年)
机译:基因组相互作用靶分析显示了一种新型PEBLR20-erna激活途径,用于控制干细胞多能性
机译:全基因组CRISPR-KO筛查揭示了mTORC1介导的Gsk3调控在幼稚多能性维持和溶解中的作用
机译:生成排放信息以进行路线选择-实验监测和路线表征
机译:多能性和肝细胞癌长期非编码RNA的表征
机译:绘制从幼稚多能性到谱系规范的路线
机译:基因组 - 宽CRISPR-KO筛网在幼稚多能性维护和溶解中发现MTORC1介导的GSK3调节